This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kassem, M. Articles by Teh, B. T. Search for Related Content PubMed PubMed Citation Articles by Kassem, M. Articles by Teh, B. T.

Familial Isolated Hyperparathyroidism as a Variant of Multiple Endocrine Neoplasia Type 1 in a Large Danish Pedigree¹

University Department of Endocrinology and Metabolism, Aarhus Amtssyghus (M.K.), Aarhus, Denmark; the Department of Clinical Biochemistry and Genetics, KKA, Odense University Hospital (T.A.K.), Odense C, Sweden; Endocrine Tumor Unit, Department of Molecular Medicine, Karolinska Hospital (F.K.W., C.L., B.T.T.), S-171 76 Stockholm, Sweden; and Van Andel Research Institute (B.T.T.), Michigan

Address all correspondence and requests for reprints to: Dr. Catharina Larsson, Endocrine Tumor Unit, Karolinska Hospital, CMM L8:01, S-171 76 Stockholm, Sweden. E-mail: catharina.larsson{at}cmm.ki.se

We report here our genetic findings of a family in which 14 members were affected with isolated primary hyperparathyroidism. Hyperparathyroidism is the main feature of multiple endocrine neoplasia type 1 (MEN1), making the recently cloned MEN1 gene a prime candidate gene in this family. Significantly positive lod scores were achieved with D11S4946 (3.36) and D11S4940 (3.53), and by combining the results from these two markers, a maximum positive lod score of 4.12 at recombination fraction 0.00 was obtained. Mutation analysis of MEN1 performed by full sequencing identified a missense mutation in exon 4, causing an amino acid change from glutamine to proline at codon 260. This mutation (Q260P) was present in all affected family members, and the inheritance of the mutation was in complete agreement with the disease-associated haplotype. In comparison with the recent functional studies of the menin protein interactions, this mutation is located in a region with little or no binding activity to JunD and activating protein-1 transcription factor. We conclude that some of the familial isolated primary hyperparathyroidism families constitute a milder variant of MEN 1, which is associated with a functionally milder missense mutation.

This article has been cited by other articles:

				M. C Lemos, B. Harding, A. A C Reed, J. Jeyabalan, G. V Walls, M. R Bowl, J. Sharpe, S. Wedden, J. E Moss, A. Ross, et al. Genetic background influences embryonic lethality and the occurrence of neural tube defects in Men1 null mice: relevance to genetic modifiers J. Endocrinol., October 1, 2009; 203(1): 133 - 142. [Abstract] [Full Text] [PDF]

				D M Lourenco Jr, R A Toledo, I I Mackowiak, F L Coutinho, M G Cavalcanti, J E M Correia-Deur, F Montenegro, S A C Siqueira, L C Margarido, M C Machado, et al. Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile Eur. J. Endocrinol., September 1, 2008; 159(3): 259 - 274. [Abstract] [Full Text] [PDF]

				V. M. Howell, J. W. Cardinal, A.-L. Richardson, O. Gimm, B. G. Robinson, and D. J. Marsh Rapid Mutation Screening for HRPT2 and MEN1 Mutations Associated with Familial and Sporadic Primary Hyperparathyroidism J. Mol. Diagn., November 1, 2006; 8(5): 559 - 566. [Abstract] [Full Text] [PDF]

				S. J. Marx and W. F. Simonds Hereditary Hormone Excess: Genes, Molecular Pathways, and Syndromes Endocr. Rev., August 1, 2005; 26(5): 615 - 661. [Abstract] [Full Text] [PDF]

				F. Cetani, E. Pardi, S. Borsari, P. Viacava, G. Dipollina, L. Cianferotti, E. Ambrogini, E. Gazzerro, G. Colussi, P. Berti, et al. Genetic Analyses of the HRPT2 Gene in Primary Hyperparathyroidism: Germline and Somatic Mutations in Familial and Sporadic Parathyroid Tumors J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5583 - 5591. [Abstract] [Full Text] [PDF]

				W. Hao, M. C. Skarulis, W. F. Simonds, L. S. Weinstein, S. K. Agarwal, C. Mateo, L. James-Newton, G. R. Hobbs, F. Gibril, R. T. Jensen, et al. Multiple Endocrine Neoplasia Type 1 Variant with Frequent Prolactinoma and Rare Gastrinoma J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3776 - 3784. [Abstract] [Full Text] [PDF]

				C. A. Carrasco, A. A. Gonzalez, C. A. Carvajal, C. Campusano, E. Oestreicher, E. Arteaga, N. Wohllk, and C. E. Fardella Novel Intronic Mutation of MEN1 Gene Causing Familial Isolated Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4124 - 4129. [Abstract] [Full Text] [PDF]

				J Warner, M Epstein, A Sweet, D Singh, J Burgess, S Stranks, P Hill, D Perry-Keene, D Learoyd, B Robinson, et al. Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications J. Med. Genet., March 1, 2004; 41(3): 155 - 160. [Abstract] [Full Text] [PDF]

				A Villablanca, A Calender, L Forsberg, A Hoog, J-D Cheng, D Petillo, C Bauters, K Kahnoski, T Ebeling, P Salmela, et al. Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP) J. Med. Genet., March 1, 2004; 41(3): e32 - 32. [Full Text] [PDF]

				W. F. Simonds, C. M. Robbins, S. K. Agarwal, G. N. Hendy, J. D. Carpten, and S. J. Marx Familial Isolated Hyperparathyroidism Is Rarely Caused by Germline Mutation in HRPT2, the Gene for the Hyperparathyroidism-Jaw Tumor Syndrome J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 96 - 102. [Abstract] [Full Text] [PDF]

				J. J. O. Turner, P. D. Leotlela, A. A. J. Pannett, S. A. Forbes, J. H. D. Bassett, B. Harding, P. T. Christie, D. Bowen-Jones, S. Ellard, A. Hattersley, et al. Frequent Occurrence of an Intron 4 Mutation in Multiple Endocrine Neoplasia Type 1 J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2688 - 2693. [Abstract] [Full Text] [PDF]

				M. A. Kouvaraki, J. E. Lee, S. E. Shapiro, R. F. Gagel, S. I. Sherman, R. V. Sellin, G. J. Cote, and D. B. Evans Genotype-Phenotype Analysis in Multiple Endocrine Neoplasia Type 1 Arch Surg, June 1, 2002; 137(6): 641 - 647. [Abstract] [Full Text] [PDF]

				M. L. Brandi, R. F. Gagel, A. Angeli, J. P. Bilezikian, P. Beck-Peccoz, C. Bordi, B. Conte-Devolx, A. Falchetti, R. G. Gheri, A. Libroia, et al. CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2 J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5658 - 5671. [Abstract] [Full Text] [PDF]

				S. S. Guo and M. P. Sawicki Molecular and Genetic Mechanisms of Tumorigenesis in Multiple Endocrine Neoplasia Type-1 Mol. Endocrinol., October 1, 2001; 15(10): 1653 - 1664. [Abstract] [Full Text] [PDF]

				B.M. Cavaco, L. Barros, A.A.J. Pannett, L. Ruas, M. Carvalheiro, M.M.A. Ruas, T. Krausz, M.A. Santos, L.G. Sobrinho, V. Leite, et al. The hyperparathyroidism-jaw tumour syndrome in a Portuguese kindred QJM, April 1, 2001; 94(4): 213 - 222. [Abstract] [Full Text] [PDF]

				S KYTÖLÄ, A VILLABLANCA, T EBELING, B NORD, C LARSSON, A HÖÖG, F K WONG, M VÄLIMÄKI, O VIERIMAA, B T TEH, et al. Founder effect in multiple endocrine neoplasia type 1 (MEN 1) in Finland J. Med. Genet., March 1, 2001; 38(3): 185 - 189. [Full Text]

				S. J. Marx Hyperparathyroid and Hypoparathyroid Disorders N. Engl. J. Med., December 21, 2000; 343(25): 1863 - 1875. [Full Text] [PDF]

				C. Larsson Editorial: Dissecting the Genetics of Hyperparathyroidism--New Clues from an Old Friend J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1752 - 1754. [Full Text]